IBD Registry in a Sub-Saharan African Population

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.

NCT Number	NCT04178408
Lead Sponsor	University of Zimbabwe Collaborators: Swiss IBDnet, University of Bern
Conditions	Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Enrollment	100 participants
Start Date	2021-01-02
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-07-11